These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32022136)

  • 1. Assessment of ventilatory function in patients with spinocerebellar ataxia type 2.
    Mello NM; Zonta MB; Teive HAG; Meira AT; Lopes Neto FDN; Silva JTDSND; Camargo CHF; Zeigelboim BS
    Arq Neuropsiquiatr; 2020 Feb; 78(2):96-102. PubMed ID: 32022136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionality and disease severity in spinocerebellar ataxias.
    Cruz GCD; Zonta MB; Munhoz RP; Mello NM; Meira AT; Nunes MCA; Aranha NTG; Camargo CHF; Lopes Neto FDN; Teive HAG
    Arq Neuropsiquiatr; 2022 Feb; 80(2):137-144. PubMed ID: 35352753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in individuals with spinocerebellar ataxia type 10: a preliminary study.
    Santos LR; Teive HAG; Lopes Neto FDN; Macedo ACB; Mello NM; Zonta MB
    Arq Neuropsiquiatr; 2018 Aug; 76(8):527-533. PubMed ID: 30231126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of disease duration on functional status of patients with spinocerebellar ataxia type 2.
    Amarante TRP; Takeda SYM; Teive HAG; Zonta MB
    Arq Neuropsiquiatr; 2017 Nov; 75(11):773-777. PubMed ID: 29236819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing loss of balance and functional capacity among patients with SCA2, SCA3 and SCA10.
    Zonta MB; Teive HAG; Camargo CHF; Meira AT; Lopes Neto FDN; Tensini FS; Braga CB; Ashizawa T; Munhoz RP
    Clin Neurol Neurosurg; 2022 Mar; 214():107150. PubMed ID: 35123369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.
    Monte TL; Reckziegel EDR; Augustin MC; Locks-Coelho LD; Santos ASP; Furtado GV; de Mattos EP; Pedroso JL; Barsottini OP; Vargas FR; Saraiva-Pereira ML; Camey SA; Leotti VB; Jardim LB;
    Orphanet J Rare Dis; 2018 Jan; 13(1):20. PubMed ID: 29370806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
    Tanguy Melac A; Mariotti C; Filipovic Pierucci A; Giunti P; Arpa J; Boesch S; Klopstock T; Müller Vom Hagen J; Klockgether T; Bürk K; Schulz JB; Reetz K; Pandolfo M; Durr A; Tezenas du Montcel S;
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):559-565. PubMed ID: 29279305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 2.
    Yang L; Shao YR; Li XY; Ma Y; Dong Y; Wu ZY
    Neurology; 2021 Dec; 97(24):e2404-e2413. PubMed ID: 34706976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2.
    Dabla S; Garg D; Aggarwal R; Kumar N; Faruq M; Rajan R; Shukla G; Goyal V; Pandey RM; Srivastava AK; Dabla S; Garg D; Shukla G
    Ann Indian Acad Neurol; 2022; 25(4):647-653. PubMed ID: 36211176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with autosomal dominant spinocerebellar ataxia have more risk of falls, important balance impairment, and decreased ability to function.
    Aizawa CY; Pedroso JL; Braga-Neto P; Callegari MR; Barsottini OG
    Arq Neuropsiquiatr; 2013 Aug; 71(8):508-11. PubMed ID: 23982006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scale for the assessment and rating of ataxia: Age-dependent performance of healthy adults.
    Grobe-Einsler M; Schmidt A; Schaprian T; Vogt IR; Klockgether T
    Eur J Neurol; 2023 Feb; 30(2):548-551. PubMed ID: 36214603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.